Stock LFMD LIFEMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings LifeMD, Inc.

Equities

LFMD

US53216B1044

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.25 USD -2.94% Intraday chart for LifeMD, Inc. +5.23% -0.48%
May. 09 Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating MT
May. 08 LifeMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
LIFEMD, INC. Stock LifeMD, Inc.
-0.48% 349M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-9.49% 28.16B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+25.35% 8.33B
C-
SECTRA AB Stock Sectra AB
+33.25% 4.39B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-35.85% 2.43B
C-
VERADIGM INC. Stock Veradigm Inc.
-9.44% 1.6B -
C+
OMNICELL, INC. Stock Omnicell, Inc.
-13.39% 1.5B
B
LUNIT INC. Stock Lunit Inc.
-32.84% 1.15B -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+7.80% 964M
C
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-37.56% 872M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. LFMD Stock
  4. Ratings LifeMD, Inc.